TMC-647055

DB11822InvestigationalSmall molecule

TMC647055 has been used in trials studying the treatment of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, and Chronic Hepatitis C Virus.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₃₂H₃₈N₄O₆S · 606.74 g/mol (avg)
Code names: TMC647055

Resolves to

Compound

Structure

InChIKeyUOBYJVFBFSLCTQ-UHFFFAOYSA-NSMILESCOC1=CC=C2C3=C(C4CCCCC4)C4=CC=C5C=C4N3CC(=CC2=C1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with TMC-647055, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.